Related Experiment Video
Updated: Apr 14, 2026
14:10
Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
16.6K
CavitoMod-UTMDNet: A Mechanistic Cavitation-Diffusion Framework for Ultrasound-Targeted Microbubble
Yazeed Alashban1, Ghada Moh Samir Elhessewi2, Mohammed Maray3
1Department of Radiological Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
Cancer Biotherapy & Radiopharmaceuticals
|April 13, 2026
Summary
Ultrasound-targeted microbubble cavitation (UTMD) enhances liposomal doxorubicin delivery for pancreatic cancer. This method improves drug uptake and reduces tumor volume without toxicity, offering a promising strategy for PDAC treatment.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Pancreatic ductal adenocarcinoma (PDAC) presents treatment challenges due to its dense stroma, poor vascularity, and high interstitial fluid pressure, hindering chemotherapy efficacy.
- Liposomal doxorubicin shows improved pharmacokinetics but faces barriers in PDAC delivery due to nanoparticle interactions with stromal and vascular components.
Purpose of the Study:
- To introduce CavitoMod-UTMDNet, an integrated platform using ultrasound-targeted microbubble cavitation (UTMD) to overcome PDAC treatment barriers.
- To enhance vascular and stromal permeability for improved intratumoral delivery of liposomal doxorubicin.
Main Methods:
- Combined Rayleigh-Plesset cavitation modeling, Fickian diffusion analysis, and a two-compartment pharmacokinetic model.
- In vitro and in vivo validation using pancreatic cancer cell lines and orthotopic mouse models.
- Passive cavitation detection to establish stable cavitation exposure windows within FDA limits.
Main Results:
- UTMD significantly increased intracellular drug uptake (3.2-3.8 fold) and reduced IC50 by ~50% in pancreatic cancer cell lines.
- Intratumoral drug delivery was improved 2.4-fold in mouse models, leading to a 54% tumor volume reduction over 21 days.
- No significant hepatic, renal, or cardiac toxicity was observed.
Conclusions:
- Established mechanistic links between cavitation energy density, drug uptake, diffusion depth, and therapeutic response.
- CavitoMod-UTMDNet provides a physics-based, reproducible strategy for optimizing ultrasound-enhanced nanocarrier delivery in PDAC.
- This approach holds potential for future image-guided therapeutic strategies in pancreatic cancer treatment.
